American Heart Journal
Volume 157, Issue 3 , Pages 442-449 , March 2009

Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study

  • Julie A. Johnson, PharmD

      Affiliations

    • University of Florida College of Pharmacy and Center for Pharmacogenomics, Gainesville, FL
    • University of Florida College of Medicine, Gainesville, FL
    • Corresponding Author InformationReprint requests: Julie A. Johnson, PharmD, University of Florida, Box 100486, Gainesville, FL 32610-0486.
  • ,
  • Eric Boerwinkle, PhD

      Affiliations

    • University of Texas at Houston Center for Human Genetics, Houston, TX
  • ,
  • Issam Zineh, PharmD

      Affiliations

    • University of Florida College of Pharmacy and Center for Pharmacogenomics, Gainesville, FL
    • University of Florida College of Medicine, Gainesville, FL
  • ,
  • Arlene B. Chapman, MD

      Affiliations

    • Emory University School of Medicine, Atlanta, GA
  • ,
  • Kent Bailey, PhD

      Affiliations

    • Mayo Clinic College of Medicine, Rochester, MN
  • ,
  • Rhonda M. Cooper-DeHoff, PharmD, MS

      Affiliations

    • University of Florida College of Pharmacy and Center for Pharmacogenomics, Gainesville, FL
    • University of Florida College of Medicine, Gainesville, FL
  • ,
  • John Gums, PharmD

      Affiliations

    • University of Florida College of Pharmacy and Center for Pharmacogenomics, Gainesville, FL
    • University of Florida College of Medicine, Gainesville, FL
  • ,
  • R. Whit Curry, MD

      Affiliations

    • University of Florida College of Medicine, Gainesville, FL
  • ,
  • Yan Gong, PhD

      Affiliations

    • University of Florida College of Pharmacy and Center for Pharmacogenomics, Gainesville, FL
  • ,
  • Amber L. Beitelshees, PharmD, MPH

      Affiliations

    • University of Florida College of Pharmacy and Center for Pharmacogenomics, Gainesville, FL
  • ,
  • Gary Schwartz, MD

      Affiliations

    • Mayo Clinic College of Medicine, Rochester, MN
  • ,
  • Stephen T. Turner, MD

      Affiliations

    • Mayo Clinic College of Medicine, Rochester, MN

Received 2 September 2008 ,Accepted 26 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work is funded by the National Institutes of Health (Bethesda, MD; grant U01-GM074492), as part of the Pharmacogenetics Research Network.

PII: S0002-8703(08)01041-7

doi: 10.1016/j.ahj.2008.11.018

American Heart Journal
Volume 157, Issue 3 , Pages 442-449 , March 2009